Lac/harbor-UCLA Med Center
Acute Care Hospitals · Government - Local
1000 W Carson St
Torrance, CA 90509
- Emergency services
- Medicare overall rating: 1 of 5 stars
At a glance
- Clinicians who list this hospital
- 303
- Physicians (MD and DO)
- 249
- Residents and fellows in training (full-time equivalents, fiscal year 2025)
- 506
- Medical groups
- 15+
Quality and patient experience
- Medicare overall rating (of 5)
- 1
- Patient survey rating (of 5)
- 2
- Patients who would definitely recommend it (national average 71%)
- 61%
Compared with the national rate
| Measures | Better | Same | Worse |
|---|---|---|---|
| Deaths after treatment | 0 | 7 | 0 |
| Safety of care (infections, complications) | 1 | 5 | 1 |
| Readmissions and return visits | 0 | 6 | 1 |
Number of Medicare quality measures where this hospital’s rate is statistically better than, the same as (no different from), or worse than the national rate.
What patients said
- Doctors communicated well 2 of 5 stars
- Nurses communicated well 1 of 5 stars
- Explained medicines 2 of 5 stars
- Discharge information 3 of 5 stars
- Clean 1 of 5 stars
- Quiet at night 1 of 5 stars
From 1,594 patient surveys (HCAHPS), period ending 09/30/2025.
Medicare “birthing-friendly” hospital: takes part in a maternity care quality program and follows recommended safety practices.
Source: CMS Care Compare (Hospital General Information; Patient survey HCAHPS). Ratings describe the hospital overall, not individual doctors.
Physicians by specialty
- Internal Medicine 36
- Family Medicine 36
- Emergency Medicine 33
- Ophthalmology 17
- Endocrinology & Diabetes 11
- Cardiology 11
- Nephrology (Kidney) 10
- Orthopedic Surgery 9
- Dermatology 7
- Gastroenterology 7
- Psychiatry 7
- Hematology & Oncology 5
- Hospitalist 3
- Vascular Surgery 3
- Neurosurgery 3
- Neurology 3
- General Surgery 3
- Interventional Radiology 3
- Urology 3
- Retina Specialist 2
- Pain Medicine 2
- Plastic Surgery 2
- Urogynecology 2
- Cardiothoracic Surgery 2
- Pulmonology 2
- Sports Medicine 2
- Rheumatology 2
- ENT (Otolaryngology) 2
- Spine Surgery 2
- Hand Surgery 2
- Geriatric Medicine 2
- Cardiac Electrophysiology 2
- Pediatric Emergency Medicine 2
- Infectious Disease 2
- General Practice 1
- Gynecologic Oncology 1
- Hematology 1
- Radiology 1
- Radiation Oncology 1
- Critical Care Medicine 1
- Interventional Cardiology 1
- Mohs Surgery 1
- OB-GYN (Obstetrics & Gynecology) 1
Other clinicians
Medical groups whose clinicians work here
- County of Los Angeles 81
- Prohealth PArtners, A Medical Group 16
- Jules Stein Eye Institute Medical Group 10
- Torrance Health Association Inc 6
- Intercommunity Emergency Medical Group 4
- Bandb Medical Group Inc 4
- Golden State Emergency Physicians Inc 4
- Ocean Skin and Vein Institute 3
- Los Angeles County Department of Mental Health 3
- St. John's Community Health 3
- Venice Family Clinic 3
- The Regents of the University of California 3
- Palomar Emergency Physicians, Inc 2
- Wills Eye Ophthalmology Clinic, Inc 2
- Sharwin Tafazoli Inc 2
Number of each group’s clinicians who list this hospital.
Industry-funded research here
Drug and device companies reported $184,035 in research payments to this hospital in 2025 for 8 studies.
- A study of TAK-330 for reversal of direct oral factor xa inhibitor-induced anticoagulation
Takeda Pharmaceuticals U.S.A., Inc. · $75,864 - A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy
Takeda Pharmaceuticals U.S.A., Inc. · $39,089 · Completed - Engulf
Endovascular Engineering Inc. · $20,998 - A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Below-the-Knee (BTK) Atherosclerotic Disease in Patient…
M.a. Med Alliance S.a. · $15,200 - A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels
M.a. Med Alliance S.a. · $12,160 - TAK-665-4003: an open-label, multicenter, phase 4 study to assess the effects of a prophylactic immune tolerizing regimen in mps ii treatment-nave patients planned to receive elaprase who are at risk of developing per…
Takeda Pharmaceuticals U.S.A., Inc. · $9,990 - A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis
M.a. Med Alliance S.a. · $6,880 - Post-Trial Access (PTA) Program for Patients with Metachromatic Leukodystrophy who Received the Drug SHP611 While Participating in the SHP611-201 or HGT-MLD-070/071 studies
Takeda Pharmaceuticals U.S.A., Inc. · $3,854
From CMS Open Payments research payments to this hospital as a teaching hospital. Payments to affiliated universities or research foundations are reported under those names. All industry-funded trials →
Sources: CMS Hospital General Information and Doctors and Clinicians Facility Affiliation (Care Compare), CMS certification number 050376. Counts are clinicians who list this hospital with Medicare; they include part-time and visiting clinicians and aren’t staff totals. Residents and beds are from the hospital’s Medicare cost report. Ratings are Medicare’s, not ours.